Proliferating cell nuclear antigen (PCNA): expression in samples of human astrocytic gliomas

Neuropathol Appl Neurobiol. 1993 Apr;19(2):152-8. doi: 10.1111/j.1365-2990.1993.tb00421.x.

Abstract

In this retrospective study, 55 astrocytic tumours were stained with monoclonal antibody PC10 which recognizes the proliferating cell nuclear antigen (PCNA) in formalin fixed, paraffin-wax embedded sections. All the cases were graded using the Daumas-Duport system and the PCNA labelling indices (LIs) were correlated with tumour grades. Mean PCNA LI was 4.1% in the grade II, 8.1% in the grade III and 26.1% in the grade IV group. Six juvenile and cerebellar (grade I) astrocytomas had a mean PCNA LI of 5.6%. In general PCNA LI increased with tumour grade, but there was considerable variation of LIs especially in grade IV tumours which often had very high PCNA LIs (up to 72.7%). PC10 may be a useful complementary technique in surgical neuropathology, but the significance of the high LIs, seen in a proportion of glioblastomas, needs to be further determined.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Monoclonal
  • Antigens, Neoplasm / biosynthesis*
  • Brain Neoplasms / immunology*
  • Brain Neoplasms / pathology
  • Child
  • Glioblastoma / immunology*
  • Glioblastoma / pathology
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Nuclear Proteins / biosynthesis*
  • Paraffin Embedding
  • Proliferating Cell Nuclear Antigen
  • Retrospective Studies

Substances

  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Nuclear Proteins
  • Proliferating Cell Nuclear Antigen